Synopsys, Inc. (SNPS) Stock Forecasts

Argus lowered its target price for Synopsys (SNPS) to $507.00. The company provides electronic design automation software and intellectual property products, aiding in chip design. This update may impact investor expectations for SNPS.

Original reporting
Published Oct 21, 2026, 11:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SNPS
Bearish
high confidence
Mentioned
$SNPS
Relevance
7/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$SNPSBearishMed
01

Why it matters

The target price reduction reflects analyst concerns about growth or competitive pressures.

02

Market read

Analyst downgrade may trigger short-term sell pressure in SNPS.

03

What to watch

Potential upcoming product launches or contract wins could offset the downgrade.

Relevance 7/10Novelty 6/10Timing: today

Background

Synopsys provides electronic design automation tools for chip design.

Company-level read

Ticker impact

$SNPSBearishHigh confidence
Context

Analyst lowered Synopsys target price to $507.00.

Expected impact

likely downside pressure as investors price in the reduced target.

Evidence & confidence

A target price reduction is a direct valuation downgrade, prompting sell pressure.

Market effects

May weigh on other EDA software peers as valuation expectations adjust.

Limited to US tech sector, no broad regional effect.

Minimal global impact beyond semiconductor design industry.

Counterpoint

Some investors may view the cut as an overreaction and look for buying opportunity.

Key entities

  • Synopsys, Inc.

    Provider of EDA software and IP products.

Related articles

$SNPSMed

Why is Synopsys stock sliding today?

Synopsys (SNPS) stock fell 2.0% to $456.73 after Anthropic's IPO roadshow highlighted AI-driven chip design, raising competition concerns. The stock has declined further from its 52-week high of $539.48, with One Way Holdings LLC reducing its position by 99%. Investors are evaluating Synopsys's valuation and integration risks amid broader market uncertainty.

$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.

$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.